Teva- Pharmaceutical Industries (TEVA) EBITDA (2017 - 2026)
Teva- Pharmaceutical Industries (TEVA) EBITDA from Mar 31, 2017 to Mar 31, 2026. The TTM Teva- Pharmaceutical Industries (TEVA) EBITDA is $3.29B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Teva- Pharmaceutical Industries (TEVA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +124.37% |
Annual EBITDA change of Teva- Pharmaceutical Industries (TEVA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $891M | -71.79% |
| 2025 | $3.16B | +317.86% |
| 2024 | $756M | -52.33% |
| 2023 | $1.59B | -278.40% |
| 2022 | -$889M | -129.19% |
| 2021 | $3.05B | -251.17% |
| 2020 | -$2.02B | -257.54% |
| 2019 | $1.28B | +523.90% |
| 2018 | $205M | -101.33% |
| 2017 | -$15B | -517.94% |
| 2016 | $3.68B | -21.07% |
| 2015 | $4.66B | -14.64% |
| 2014 | $5.46B | +65.88% |
| 2013 | $3.29B | -15.90% |
| 2012 | $3.91B | -6.34% |
| 2011 | $4.18B | -13.82% |
| 2010 | $4.85B | +46.33% |
| 2009 | $3.31B | +102.63% |
| 2008 | $1.64B | -43.50% |
| 2007 | $2.89B | N/A |